Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Resmed Inc
(NY:
RMD
)
250.88
-0.89 (-0.35%)
Official Closing Price
Updated: 4:10 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Resmed Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Nasdaq Futures Slip As Nvidia Sell-Off Continues, S&P 500 Futures Hold Up: Analyst Says 'Valuations Will Go Parabolic And It Will Be A Perfect Time To Sell'
June 24, 2024
The U.S.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
(RMD) - Analyzing ResMed's Short Interest
June 20, 2024
Via
Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $11,000 Today
June 17, 2024
Via
Benzinga
Elliott Wave Technical Forecast: Unlocking ASX Trading Success: ResMed Inc
June 17, 2024
The analysis aims to provide readers with insights into the current market trends and how to capitalize on them effectively.
Via
Talk Markets
Stryker Stock Sees RS Rating Treks Higher To 71
May 29, 2024
Stryker stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 63 to 71.
Via
Investor's Business Daily
$100 Invested In ResMed 20 Years Ago Would Be Worth This Much Today
May 29, 2024
Via
Benzinga
(RMD) - Analyzing ResMed's Short Interest
May 27, 2024
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
May 17, 2024
Via
Benzinga
(RMD) - Analyzing ResMed's Short Interest
April 30, 2024
Via
Benzinga
Betting on Nvidia: 3 ETFs to Own for Exposure to the AI Giant
May 23, 2024
Explore three ETFs with Nvidia exposure to capitalize on the future of AI without having to pick a single winner.
Via
InvestorPlace
Topics
Artificial Intelligence
ETFs
Exposures
Artificial Intelligence
All-Time Highs In Sight: The Critical Signals You Can't Ignore
May 15, 2024
Is the S&P 500 showing signs of a sustainable rally, or are we headed for a pullback?
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Top Research Reports For Apple, Linde & Comcast
May 06, 2024
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Linde plc (LIN) and Comcast Corporation (CMCSA).
Via
Talk Markets
Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78
April 30, 2024
On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.
Via
Investor's Business Daily
Why ResMed Stock Is Soaring Today
April 26, 2024
Investors liked the healthcare technology company's latest quarterly update.
Via
The Motley Fool
Why NYSE:RMD qualifies as a good dividend investing stock.
April 08, 2024
Why the dividend investor may take a look at RESMED INC (NYSE:RMD).
Via
Chartmill
Expert Outlook: ResMed Through The Eyes Of 9 Analysts
March 27, 2024
Via
Benzinga
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 26, 2024
Via
Benzinga
Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday
April 26, 2024
Via
Benzinga
ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes
April 26, 2024
ResMed is the biggest maker of CPAPs in the U.S., and says the growing popularity of weight-loss drugs could help diagnosis rates.
Via
Investor's Business Daily
ResMed Analysts Boost Their Forecasts After Better-Than-Expected Earnings
April 26, 2024
Via
Benzinga
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
April 26, 2024
Via
Benzinga
Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn't Over Yet
April 26, 2024
Tech earnings could come to the market’s rescue as traders remain jittery about the outcome of key inflation data due on Friday.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
RMD Stock Earnings: ResMed Beats EPS, Beats Revenue for Q3 2024
April 25, 2024
RMD stock results show that ResMed beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
April 25, 2024
Via
Benzinga
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
April 18, 2024
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
Via
Investor's Business Daily
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
April 17, 2024
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
Via
The Motley Fool
Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
April 17, 2024
The results also pressured ResMed, a maker of CPAPs. CPAPs are the common treatment for sleep apnea.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
April 15, 2024
Via
Benzinga
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
April 08, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER).
Via
Benzinga
$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
March 28, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.